Hikma: API facility bolsters our oncology pipeline

By Dan Stanton contact

- Last updated on GMT

Hikma: API facility bolsters our oncology pipeline

Related tags: Pharmaceutical drug

Hikma has opened a new API facility in Jordan to support its oncology pipeline.

The new facility is located in Amman, Jordan and is an extension to an existing active pharmaceutical ingredient (API) site, adjacent to the company’s headquarters.

The site was inaugurated last week by King Abdallah of Jordan and will produce the raw materials for Hikma’s pipeline.

“Currently we’ve 5 oncology APIs in the development pipelines,”​ Hikma spokesman Ben Atwell was able to tell in-Pharmatechnologist.com, though he did not reveal more information about the new site or how it would support Hikma’s API network.

In 2011​, the firm invested $33m (€23m) in a joint venture with Indian API and intermediate firm Unimark Remedies in order to develop specialised APIs.

Recently the firm has been focusing on the sterile injectables market, having rebuffed offers to sell its ‘lucrative’ business last year to Amgen and Novartis​, and buying Ohio-based Bedford Labs​ – and subsequently troubled manufacturer Ben Venue Labs - for $300m in May.

Related news

Show more

Related products

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers